Empagliflozin-induced liver injury
Background: Drug-induced liver injury is an uncommon, idiosyncratic adverse reaction with heterogeneous clinical presentations, ranging from asymptomatic transaminase elevations to acute liver failure.
Hélder Diogo Gonçalves +6 more
doaj +1 more source
Drug-induced chronic liver injury [PDF]
Lara, Dakhoul +2 more
openaire +2 more sources
Role of metabolic nuclear receptors in acute liver injury and drug-induced hepatotoxicity
Metabolic nuclear receptors (NRs) are ligand-activated transcription factors central to metabolic homeostasis and detoxification. While their roles in chronic liver diseases have been reviewed, comprehensive reviews specifically addressing the role of ...
Liangliang Nie +4 more
doaj +1 more source
Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway. [PDF]
Tumor recurrence remains an obstacle after liver surgery, especially in living donor liver transplantation (LDLT) for patients with hepatocellular carcinoma (HCC).
Geng, Wei +9 more
core +1 more source
Insights into the Biochemical and Immune Mechanisms in Drug-Induced Liver Injury Pathogenesis. [PDF]
Saville E +4 more
europepmc +1 more source
Anti-Tubercular Drug-Induced Liver Injury: Current Understanding and Emerging Directions. [PDF]
Prasad S, Narang H, Kedia S, Ahuja V.
europepmc +1 more source
A human liver organoids-on-chip for the assessment of drug-induced liver injury. [PDF]
Chen X +6 more
europepmc +1 more source
The incidence of chronic drug-induced liver injury: a systematic review and meta-analysis. [PDF]
Zhang Y, Ren YL, Song XR, He XJ, Wen XY.
europepmc +1 more source
Metabolic heterogeneity, networks, and biomarkers of drug-induced liver injury. [PDF]
Ding X +8 more
europepmc +1 more source

